The Big View

331 Episodes

1. AstraZeneca’s Soriot on cures for pharma ills

   Published: 8/30/2022
2. Australia’s investing giant is taking on the world

   Published: 8/23/2022
3. Thoma Bravo is riding the tech downturn

   Published: 8/2/2022
4. ESG is more of a muddle than a fiddle

   Published: 7/19/2022
5. GSK’s bid to dominate longer-life HIV drugs

   Published: 7/5/2022
6. Hong Kong’s last governor on dealing with China

   Published: 6/21/2022
7. Pete Stavros and his equity-for-all quest

   Published: 5/31/2022
8. How Brooks ran into Warren Buffett’s arms

   Published: 4/26/2022
9. Australia can charge up a war on climate change

   Published: 4/12/2022
10. The cost of corporate kowtowing to China

    Published: 4/5/2022
11. Why U.S.-China financial tension is hard to disarm

    Published: 3/29/2022
12. How Mad Men are waking up to the metaverse

    Published: 3/22/2022
13. The climate revolution is underhyped

    Published: 3/15/2022
14. VCs are victims of their own success

    Published: 3/8/2022
15. Ukraine war is tectonic shift for global finance

    Published: 3/1/2022
16. The Exchange: Why economic walls don’t work

    Published: 2/22/2022
17. The Exchange: Consumers have the retail whip hand

    Published: 2/15/2022
18. The Exchange: Margrethe Vestager

    Published: 2/8/2022
19. The Exchange: UniCredit’s Andrea Orcel

    Published: 2/3/2022
20. The Exchange: San Francisco Fed boss Mary Daly

    Published: 2/1/2022